The National Agency for Food and Drug Administration and Control (NAFDAC) has discontinued the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
Trending
- NCDC taps PR networks to deepen communication of development agenda
- Nigeria’s 2026 wet season harvest shows modest growth
- CJID announces 2026 media, development conference
- ANPA calls for sustainable diaspora health partnerships
- AFAN: Guarantee minimum prices to protect farmers
- CBN clears Milestone Global Bank for regional non-interest operations
- CAPRIGHTS-VP warns against child domestic servitude
- NDLEA urges research to tackle emerging addiction risks
